A new SLAffinity titanium dental implant clinical trial research and discussion

• Main Authors: Guan-Jung Chen, 陳冠仲
• Other Authors: 黃茂栓
• Format: Others
• Language: zh-TW
• Published: 2015
• Online Access: http://ndltd.ncl.edu.tw/handle/97570783342053965149

碩士 === 臺北醫學大學 === 牙醫學系碩博士班 === 103 === For the use of the first domestically certified implant system Ti-one® 101 (HC-Bios dental implant system) by the Department of Health, to reveal the innovative hydrophilic-surface treatment technology SLAffinity . SLAffinity surface treatment has the excellent hemotrophic property due to micron, sub-micron and nanoscale composite holes covering on the titanium oxide layer, resulting in improved stability of the implant body and the effect of osseointegration. In animal experiments, comparing Ti-one® 101 with the surface treated with SLA system shows: whether three weeks, six weeks, nine weeks later, Ti-one® 101 has more removal torque than just SLA surface treatment, confirming that SLAffinity can accelerate bone healing and osseointegration. So our study will use Ti-one® 101 (HC-Bios dental implant system) in human clinical trials (TMU-JIRB No. 201111017), to explore this innovative surface treatment technology and the success rate of osseointegration.